I'm torn on this a bit since I enjoyed having to practice pitching concisely to new companies outside of biotech to improve that aspect, and to get new perspect

I'm torn on this a bit since I enjoyed having to practice pitching concisely to new companies outside of biotech to improve that aspect, and to get new perspectives on problems from different people, but I also did enjoy the times that we accidentally (or deliberately?) got regrouped with companies from the prior week and could catch up on progress made. Both have their place and their use, but some level of deeper relationships (as built in the first version that I went through when there were set cohorts) are definitely lacking in the current iterations. Part of it might be taking initiative to stay in touch on your own I guess.